Safety and Immunogenicity of Pneumococcal Conjugate Formulations in Healthy Adults 18 Through 49 Years of Age

Clinical trial NCT05489328 · COMPLETED

Trial details

NCT number: NCT05489328
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Pneumococcal Disease

Start date: 2022-08-15
Primary completion: 2022-10-07
Enrollment: 394

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.